Laxmi Organic Industries (LXCHEM) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
9 Jul, 2026Executive summary
Q3 and 9M FY2026 saw continued challenges in the global chemical industry, with cost optimization, asset shutdowns, and supply chain restructuring prevalent worldwide.
Demand from packaging, inks, adhesives, and pharmaceuticals remained stable quarter-on-quarter, while agrochemicals were moderate and paints/coatings weak to moderate.
The company maintained focus on productivity, commercial excellence, execution, cost discipline, and growth projects.
Unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, were approved and reviewed by the Board and auditors.
Re-appointment of Dr. Rajiv Banavali as Independent Director for a second term, subject to shareholder approval.
Financial highlights
Q3FY26 consolidated revenue was INR 7,186.82 million, down 9% year-over-year; standalone revenue was INR 7,068.72 million.
Q3FY26 consolidated PAT was INR 255.99 million, down from INR 278.15 million YoY; standalone PAT was INR 198.31 million.
Q3FY26 EBITDA was INR 499 million, down 33% YoY; adjusted EBITDA at INR 14 crore after one-time items.
One-time gain of INR 407 million from favorable litigation settlement; offset by INR 38 million labor court provision and INR 9 million supply chain redesign cost.
Employee costs rose to INR 46 crore, reflecting ESOP reversal last year, new headcount, and annual increments.
Outlook and guidance
Dahej phase two to complete by end of Q4; FY2027 will be the first year of qualification and ramp-up for new specialty products, with further ramp-up in FY2028.
Acetic acid prices expected to stabilize between $330-$380/MT, with spreads for ethyl acetate improving to $130/MT.
Specialty margins expected to gradually recover as new capacities ramp up and product mix stabilizes.
Management remains cautious, monitoring quarter-over-quarter performance due to ongoing industry volatility.
The company is committed to transparency, compliance, and stakeholder engagement.
Latest events from Laxmi Organic Industries
- Revenue up 40% and EBITDA up 272% YoY, with strong growth and margin expansion.LXCHEM
Q1 26/27 - FY26 revenue and profit declined, but Q4 margins improved and a dividend was declared.LXCHEM
Q4 25/26 - Q2 FY26 saw a 9% revenue drop and margin pressure, but cash flow and new projects support recovery.LXCHEM
Q2 25/26 - Q1FY26 revenue fell 4% despite 8% volume growth; CapEx and digitization advanced as planned.LXCHEM
Q1 25/26 - Q2FY25 revenue up 18%, EBITDA up 92%, and PAT up 162% amid major capex and merger progress.LXCHEM
Q2 24/25 - Q1 FY25 delivered revenue growth, specialty strength, and progress on capex, merger, and capital changes.LXCHEM
Q1 24/25 - 11% volume and 9.4% EBITDA growth, new projects, and YFCPL amalgamation mark FY25.LXCHEM
Q4 24/25 - Q3 and 9MFY25 saw double-digit growth, margin gains, and progress on expansion and corporate actions.LXCHEM
Q3 24/25